Ikizler Murat, Erkasap Nilüfer, Dernek Sadettin, Kural Tuğrul, Kaygisiz Ziya
Department of Cardiovascular Surgery, Eskişehir Osmangazi University, Eskişehir, Turkey.
Anadolu Kardiyol Derg. 2007 Dec;7(4):404-10.
Quercetin is an important member of dietary flavonoid family and widely present in red wine and Mediterranean diet. The major objective of the this study is to evaluate the beneficial effects of quercetin in protecting the myocardium from the deleterious effects of ischemia reperfusion (I/R) injury in chronic quercetin treatment with or without an acute quercetin infusion protocols.
Forty male Sprague-Dawley rats were included in this experimental randomized study/ Langendorff perfused isolated rat hearts were subjected to 60-min of global ischemia period following 60-min of reperfusion. All animals were randomly divided into 4 groups. Group 1 animals were kept as controls. Group 3 and 4 animals received 50 mg/kg quercetin via an intragastric tube for 7 days for chronic treatment. Group 2 and 4 animals received an acute 15 mmol/L infusion for 30 minutes before the onset of ischemia. The myocardial postischemic recovery was compared using hemodynamic data (peak systolic pressure, end-diastolic pressure and +dP/dtmax), coronary flow, biochemical parameters (lactate dehydrogenase, creatine kinase-MB fraction, cardiac troponin I) from coronary effluent, and oxidative stress markers (malondialdehyde, glutathione, glutathione reductase and nitrite) from heart tissue homogenates in each group.
Quercetin has provided increased preservation in myocardial recovery in both chronic and acute treatment protocols compared to non-treated group. According to all estimated hemodynamic parameters, while the statistical difference between acute treated hearts and control hearts was significant (p<0.05); this significance was more clear in chronic treated groups (group 3 and 4) when compared to control (p<0.01). Likewise, biochemical and oxidative stress markers displayed significant differences in acute treated and chronic treated hearts when compared to control (p<0.05 and p<0.01, respectively).
As a major dietary flavonoid, due to its antioxidant and cytoprotective actions, quercetin has the capacity to protect the myocardial tissue against global ischemia and reperfusion injury. In instances where the molecule is administered for the purpose of acute therapy, this cardioprotective effect of a significant degree can be observed to; however, this potency is further accentuated upon administration as a chronic treatment protocol for seven days.
槲皮素是膳食类黄酮家族的重要成员,广泛存在于红酒和地中海饮食中。本研究的主要目的是评估在采用或不采用急性槲皮素输注方案的慢性槲皮素治疗中,槲皮素对保护心肌免受缺血再灌注(I/R)损伤有害影响的有益作用。
本实验随机研究纳入40只雄性Sprague-Dawley大鼠。Langendorff灌注的离体大鼠心脏在60分钟再灌注后经历60分钟的全心缺血期。所有动物随机分为4组。第1组动物作为对照。第3组和第4组动物通过胃管给予50mg/kg槲皮素,持续7天进行慢性治疗。第2组和第4组动物在缺血开始前30分钟接受15mmol/L的急性输注。使用血流动力学数据(收缩压峰值、舒张末期压力和 +dP/dtmax)、冠状动脉流量、来自冠状动脉流出液的生化参数(乳酸脱氢酶、肌酸激酶-MB同工酶、心肌肌钙蛋白I)以及来自心脏组织匀浆的氧化应激标志物(丙二醛、谷胱甘肽、谷胱甘肽还原酶和亚硝酸盐)比较每组心肌缺血后的恢复情况。
与未治疗组相比,在慢性和急性治疗方案中,槲皮素均能增强心肌恢复的保存能力。根据所有估计的血流动力学参数,急性治疗的心脏与对照心脏之间的统计学差异显著(p<0.05);与对照相比,这种显著性在慢性治疗组(第3组和第4组)中更明显(p<0.01)。同样,与对照相比,急性治疗和慢性治疗的心脏中的生化和氧化应激标志物显示出显著差异(分别为p<0.05和p<0.01)。
作为一种主要的膳食类黄酮,由于其抗氧化和细胞保护作用,槲皮素具有保护心肌组织免受全心缺血和再灌注损伤的能力。在将该分子用于急性治疗的情况下,可以观察到显著程度的这种心脏保护作用;然而,作为为期7天的慢性治疗方案给药时,这种效力会进一步增强。